If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Sandomenico is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 44 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

  • Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

    Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

    Research output: Contribution to journalArticle

  • Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

    Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., 2019, In : Lung Cancer. 133, p. 62-68 7 p.

    Research output: Contribution to journalArticle

  • A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

    Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 2017, In : Lung Cancer. 108, p. 15-21 7 p.

    Research output: Contribution to journalArticle